The PwC Health Research Institute queried health plans on multiple factors, which could help employer plan sponsors take action now to deflect some of the “cost inflators” predicted to boost medical spending next year.
Confusion and lack of understanding are costing employees, their families, and their employers money and lost time. For brokers, this creates opportunities.
Merck, AstraZeneca, Bristol Myers Squibb and Boehringer Ingelheim have signed agreements to participate in the first round of Medicare drug price negotiations, while the remaining drugmakers have until Oct. 1 to decide.
Sponsored by ArmadaCare
Employee benefits can be difficult to manage--it’s certainly hard to keep everyone happy with changes to the primary plans. So, how do you respond? Access this handy interactive problem-solution guide to find out!
Sponsored by HealthComp
This report’s key findings provide valuable insights for clients considering or implementing programs aimed at cost reduction, while also wanting to ensure that employees have access to high-quality care.
Sponsored by New Ocean Health Solutions
If your health & wellness plans aren’t cohesive, don’t include costly aspects of wellness like chronic conditions, or don’t feel tailored to the specific needs of your people, it’s time to consider another solution. Download this white paper to learn how to check all the right boxes and deliver value--for both your people and your bottom line.
Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!
- Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
- Exclusive discounts on BenefitsPRO.com and ALM events.
Copyright © 2023 ALM Global, LLC. All Rights Reserved.